Universal Vision Financials
| 3218 Stock | TWD 211.00 4.00 1.86% |
Universal |
Understanding current and past Universal Vision Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Universal Vision's financial statements are interrelated, with each one affecting the others. For example, an increase in Universal Vision's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Universal Vision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Universal Vision Biotechnology. Check Universal Vision's Beneish M Score to see the likelihood of Universal Vision's management manipulating its earnings.
Universal Vision Stock Summary
Universal Vision competes with Sinphar Pharmaceutical, Grape King, Apex Biotechnology, Leatec Fine, and Information Technology. Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan. UNIVERSAL VISION is traded on Taiwan OTC Exchange in Taiwan.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0003218004 |
| Business Address | No3-1 Yuanqu Street, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.eyecenter.com.tw |
| Phone | 886 2 2655 8000 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Universal Vision without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Universal Stock, because this is throwing your money away. Analyzing the key information contained in Universal Vision's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Universal Vision Key Financial Ratios
There are many critical financial ratios that Universal Vision's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Universal Vision Bio reports annually and quarterly.Universal Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Universal Vision's current stock value. Our valuation model uses many indicators to compare Universal Vision value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Universal Vision competition to find correlations between indicators driving Universal Vision's intrinsic value. More Info.Universal Vision Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Universal Vision Biotechnology is roughly 2.09 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Universal Vision's earnings, one of the primary drivers of an investment's value.Universal Vision Bio Systematic Risk
Universal Vision's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Universal Vision volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Universal Vision Bio correlated with the market. If Beta is less than 0 Universal Vision generally moves in the opposite direction as compared to the market. If Universal Vision Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Universal Vision Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Universal Vision is generally in the same direction as the market. If Beta > 1 Universal Vision moves generally in the same direction as, but more than the movement of the benchmark.
Universal Vision Thematic Clasifications
Universal Vision Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Universal Vision November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Universal Vision help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Universal Vision Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Universal Vision Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Universal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Universal Vision's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 13.49 | |||
| Value At Risk | (2.14) | |||
| Potential Upside | 2.77 |
Additional Tools for Universal Stock Analysis
When running Universal Vision's price analysis, check to measure Universal Vision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Vision is operating at the current time. Most of Universal Vision's value examination focuses on studying past and present price action to predict the probability of Universal Vision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Vision's price. Additionally, you may evaluate how the addition of Universal Vision to your portfolios can decrease your overall portfolio volatility.